P D Schellinger

Summary

Publications

  1. doi request reprint Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial
    Peter D Schellinger
    Departments of Neurology and Neurogeriatry, Johannes Wesling Klinikum, Minden, Hans Nolte Str 1, D 32429 Minden, Germany
    Stroke 44:1606-8. 2013
  2. doi request reprint [Industry-funded therapy studies: what is in the pipeline?]
    P D Schellinger
    Neurologische Klinik und Neurogeriatrie, Johannes Wesling Klinikum Minden, Hans Nolte Str 1, 32429 Minden, Deutschland
    Nervenarzt 83:1260-9. 2012
  3. doi request reprint Assessment of additional endpoints for trials in acute stroke - what, when, where, in who?
    Peter D Schellinger
    Department of Neurology, Johannes Wesling Klinikum Minden, Minden, Germany
    Int J Stroke 7:227-30. 2012
  4. doi request reprint [Near-infrared laser treatment of acute stroke: from bench to bedside]
    P D Schellinger
    Neurologische Klinik und Neurogeriatrie, Johannes Wesling Klinikum, Hans Nolte Str 1, 32429 Minden, Deutschland
    Nervenarzt 83:966-74. 2012
  5. doi request reprint Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke
    C Blinzler
    Department of Neurology, University of Erlangen Nuremberg, Erlangen, Germany
    Cerebrovasc Dis 31:185-90. 2011

Detail Information

Publications5

  1. doi request reprint Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial
    Peter D Schellinger
    Departments of Neurology and Neurogeriatry, Johannes Wesling Klinikum, Minden, Hans Nolte Str 1, D 32429 Minden, Germany
    Stroke 44:1606-8. 2013
    ..We performed post hoc analyses of a subset of the Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) trial data set to identify whether FVP is associated with independent outcome...
  2. doi request reprint [Industry-funded therapy studies: what is in the pipeline?]
    P D Schellinger
    Neurologische Klinik und Neurogeriatrie, Johannes Wesling Klinikum Minden, Hans Nolte Str 1, 32429 Minden, Deutschland
    Nervenarzt 83:1260-9. 2012
    ..Mechanical thrombectomy is practiced in many centers although randomized trials are pending and the IMS-3 trial was stopped. This overview will cover the very recently completed and currently recruiting acute ischemic stroke trials...
  3. doi request reprint Assessment of additional endpoints for trials in acute stroke - what, when, where, in who?
    Peter D Schellinger
    Department of Neurology, Johannes Wesling Klinikum Minden, Minden, Germany
    Int J Stroke 7:227-30. 2012
    ....
  4. doi request reprint [Near-infrared laser treatment of acute stroke: from bench to bedside]
    P D Schellinger
    Neurologische Klinik und Neurogeriatrie, Johannes Wesling Klinikum, Hans Nolte Str 1, 32429 Minden, Deutschland
    Nervenarzt 83:966-74. 2012
    ..In this review we cover the theoretical background, experimental studies, translational research and the clinical trial program...
  5. doi request reprint Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke
    C Blinzler
    Department of Neurology, University of Erlangen Nuremberg, Erlangen, Germany
    Cerebrovasc Dis 31:185-90. 2011
    ..This study analyzes demographic and clinical characteristics of patients with early complete neurological recovery after thrombolysis...